In a press release, the Roche laboratory indicated that preliminary results from the SUNFISH trial showed an improvement in motor function as assessed by MFM in participants with Spinal Muscular Atrophy treated with risdisplam, compared to placebo.
You can find the press release HERE.
Recent Comments